KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Quest Diagnostics (DGX) Leases (2019 - 2026)

Quest Diagnostics' Leases history spans 11 years, with the latest figure at $691.0 million for Q1 2026.

  • On a quarterly basis, Leases rose 5.34% to $691.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $691.0 million, a 5.34% increase, with the full-year FY2025 number at $657.0 million, up 0.92% from a year prior.
  • Leases hit $691.0 million in Q1 2026 for Quest Diagnostics, up from $657.0 million in the prior quarter.
  • Over the last five years, Leases for DGX hit a ceiling of $691.0 million in Q1 2026 and a floor of $579.0 million in Q1 2024.
  • Historically, Leases has averaged $624.8 million across 5 years, with a median of $611.0 million in 2023.
  • Biggest five-year swings in Leases: dropped 5.0% in 2023 and later rose 13.3% in 2025.
  • Tracing DGX's Leases over 5 years: stood at $585.0 million in 2022, then rose by 2.91% to $602.0 million in 2023, then grew by 8.14% to $651.0 million in 2024, then grew by 0.92% to $657.0 million in 2025, then rose by 5.18% to $691.0 million in 2026.
  • Business Quant data shows Leases for DGX at $691.0 million in Q1 2026, $657.0 million in Q4 2025, and $649.0 million in Q3 2025.